EMVision Medical Devices Ltd reported earnings results for the half year ended December 31, 2022. For the half year, the company reported net loss was AUD 0.758509 million compared to AUD 2.03 million a year ago. Basic loss per share from continuing operations was AUD 0.009 compared to AUD 0.0278 a year ago.

Diluted loss per share from continuing operations was AUD 0.009 compared to AUD 0.0278 a year ago.